4EUROASPIRE.A European Society of Cardiology survey of secondary prevention of coronary heart disease:principal results.EUROASPIRE Study Group.European Action on Secondary Prevention through Intervention to Reduce Events[J].Eur Heart J,1997,18(10):1569-1582.
5Pearson TA,Mensah GA,Alexander RW,et al.Markers of inflammation and cardiovascular disease:Application to clinical and public health practice:A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association[J].Circulation,2003,107(3):499-511.
7Galle J.Atherosclerosis and arteriolitis:implications for therapy of cardiovascular disease[J].Herz,2004,29(1):4-11.
8Eikelboom JW,Hankey GJ,von Hundelshausen PB,et al.Associations of homocysteine,C-reactive protein and cardiovascular disease in patients with renal disease[J].Curr Opin Nephrol Hypertens,2001,10(3):377-383.
9Chae CU,Lee RT,Rifai N,et al.Blood pressure and inflammation in apparently healthy men[J].Hypertension,2001,38(3):399-403.
10Nieto FJ.Infections and atherosclerosis:new clues from an old hypothesis[J]? Am J Epidemiol,1998,148(10):937-948.
